Top Markets
Coin of the day
GeneThera, Inc. GeneThera, Inc.

GeneThera, Inc.

GTHR
Rangering i aksjer #42192
GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced... GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced diagnostic tools and therapeutic solutions for diseases that can transfer from animals to humans (zoonotic diseases). The company's portfolio includes treatments for a variety of these conditions, such as COVID-19, and illnesses like paratuberculosis (Johne's disease), currently in its Stage III clinical phase, as well as mad cow and chronic wasting diseases, and common bacterial infections like E.coli and salmonella. Furthermore, GeneThera is developing a vaccine specifically targeting Mycobacterium avium subspecies paratuberculosis bacteria. Utilizing its innovative Molecular Robotic/AI Platform and a strategic therapeutic framework, the company strives to inhibit the spread of animal-borne diseases and improve control over zoonotic infectious agents. GeneThera, Inc. operates out of Westminster, Colorado.
Aksjekurs
$0.0001
Sist synkronisert: 2025-03-10
Markedsverdi
$3.53K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel GeneThera, Inc. (GTHR)

Kategori

EPS for GeneThera, Inc. (GTHR)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til GeneThera, Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for GeneThera, Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter